2027 Japan Tokyo CPHI Japan International Pharmaceutical Development Exhibition

The 2027 CPHI Japan International Pharmaceutical Development Exhibition in Tokyo, as one of the leading events in the global pharmaceutical industry's CPHI series, will be grandly held at Tokyo Big Sight International Exhibition Center. Since its inception, CPHI Japan has developed into the most influential comprehensive exhibition in Japan and Asia, covering the entire pharmaceutical value chain, including pharmaceutical ingredients, finished dosage forms, biopharmaceuticals, contract services, pharmaceutical packaging, and equipment. Held annually, the exhibition brings together pharmaceutical companies, R&D institutions, suppliers, buyers, and industry experts from around the world to discuss cutting-edge technologies, market trends, and cooperation opportunities. CPHI Japan is not only a platform for showcasing the latest products and technologies but also an important bridge for promoting industry exchange and expanding international markets. During the exhibition, a series of high-level professional forums, seminars, and B2B matching events will also be held, providing excellent opportunities for exhibitors and visitors to gain in-depth knowledge of industry dynamics and establish business connections. With its strong brand influence, professional organizational capabilities, and extensive industry coverage, CPHI Japan has become the preferred platform for global pharmaceutical companies to enter the Japanese and Asian markets, seek partners, and enhance brand image. Both large multinational pharmaceutical companies and innovative startups can find resources and opportunities tailored to their development needs here, jointly promoting the innovation and development of the global pharmaceutical industry. The successful staging of the exhibition plays a pivotal role in advancing the internationalization of Japan's pharmaceutical industry and enhancing Asia's position in the global pharmaceutical supply chain.

The exhibit range of the 2027 CPHI Japan International Pharmaceutical Development Exhibition in Tokyo covers all aspects of the pharmaceutical value chain, providing exhibitors and visitors with comprehensive and in-depth industry insights. Key exhibit categories include: 1. **Pharmaceutical Ingredients (APIs) and Intermediates**: Various Active Pharmaceutical Ingredients (APIs), including chemically synthesized drugs, natural extracts, biotech drug raw materials; pharmaceutical intermediates, fine chemicals, pharmaceutical excipients, medicinal capsules, coating materials, solvents, reagents, etc. This section of exhibits forms the foundation of pharmaceutical production, showcasing the latest API R&D achievements and supply capabilities worldwide. 2. **Finished Dosage Forms**: Various oral solid dosage forms (tablets, capsules, granules), liquid dosage forms (oral solutions, injectables), semi-solid dosage forms (ointments, gels), inhaled preparations, transdermal patches, modified-release preparations, biologics, vaccines, etc. This area focuses on displaying the latest formulation technologies and products for innovative and generic drugs. 3. **Biopharmaceuticals**: Biotechnology drugs, gene-engineered drugs, cell therapy, gene therapy, antibody drugs, recombinant proteins, vaccines, diagnostic reagents, bioprocess equipment and technology, biopharmaceutical Contract Development and Manufacturing Organization (CDMO) services, etc. Biopharmaceuticals are a current hot topic in pharmaceutical R&D, and the exhibition will showcase the latest breakthroughs and development trends in this field. 4. **Contract Services**: Contract Research Organization (CRO) services, Contract Manufacturing Organization (CMO) services, Contract Development and Manufacturing Organization (CDMO) services, covering drug discovery, preclinical research, clinical trials, formulation development, process optimization, quality control, regulatory submissions, and other comprehensive services. These services are crucial for pharmaceutical companies to optimize resource allocation and accelerate new drug launches. 5. **Pharmaceutical Packaging & Machinery**: Various pharmaceutical packaging materials (glass bottles, plastic bottles, aluminum-plastic blister packs, ampoules, pre-filled syringes, pharmaceutical films, labels, anti-counterfeiting packaging, etc.); pharmaceutical machinery and equipment (granulators, tablet presses, capsule filling machines, filling machines, packaging machines, sterilization equipment, testing equipment, laboratory equipment, cleanroom equipment, water treatment equipment, etc.). Efficient and safe packaging and advanced production equipment are key to ensuring drug quality and production efficiency. 6. **Laboratory Equipment and Technology**: Analytical instruments, testing equipment, laboratory consumables, reagents, biotechnology equipment, life science research equipment, quality control systems, etc., providing technical support for drug research and development and production. 7. **Natural Extracts and Health Products**: Medicinal plant extracts, functional food ingredients, dietary supplement ingredients, health product raw materials, natural health products, etc., reflecting the growing consumer demand for natural and healthy products. 8. **Others**: Including pharmaceutical industry consulting services, intellectual property services, regulatory submission services, market analysis, industry media, industry associations, etc., providing comprehensive industry support and information services for exhibitors and visitors. These exhibits collectively form CPHI Japan's diversified platform, meeting the needs of different participants in the pharmaceutical industry.

No fee information available. Please contact us for a quote.